Fresh From the Bench: Latest Federal Circuit Court Case
CASE OF THE WEEK
CareDx, Inc. v. Natera, Inc., Appeal Nos. 2022-1027, -1028 (Fed. Cir. July 18, 2022)
In its only precedential patent opinion this week, the Federal Circuit held patents directed to the detection of organ transplant failure to be ineligible under Section 101.
The patents at issue were all owned by Stanford University and licensed to CareDx. The patents concern the detection of organ transplant failure. When a transplanted organ is rejected, the body releases cfDNA. These increased levels of cfDNA can be detected and then used to diagnose the likelihood of an organ transplant rejection.